Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer

Sponsor
UNICANCER
Study ID
NCT00005979
Phase
PHASE3
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known if combination chemotherapy is more effective with or without irinotecan in treating colon cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy with or without irinotecan in treating patients who have stage III colon cancer.

Key Dates

Start date
Jul 22, 1998
Status verified
Feb 2021
Primary completion
Sep 26, 2005
Completion
Sep 1, 2007

Study Design

Allocation
RANDOMIZED
Primary purpose
TREATMENT

Related Studies